Skip to content

TARGET XL M0036118300Recalls & reported problems

Stryker Corporation · Helical Detachable Coil · Class 2 · Implant

All models of TARGET XL (34)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613327004595), received between Mar 21, 2017 and Mar 21, 2017 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Break” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Break2

Patient problems

  • No Consequences Or Impact To Patient2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 21, 2017Break; Break

    ANALYSIS OF THE RETURNED PRODUCT REVEALED THAT THE MAIN COIL WAS BROKEN . THERE WERE NO CLINICAL CONSEQUENCES TO THE PATIENT DUE TO THIS EVENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6422362 ↗
  • MalfunctionMar 21, 2017Break; Break

    ANALYSIS OF THE RETURNED PRODUCT REVEALED THAT THE MAIN COIL WAS BROKEN. THERE WERE NO CLINICAL CONSEQUENCES TO THE PATIENT DUE TO THIS EVENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6422113 ↗

Other DEVICE, NEUROVASCULAR EMBOLIZATION devices

All DEVICE, NEUROVASCULAR EMBOLIZATION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page